Acura Pharmaceuticals Inc.

10/24/2025 | Press release | Distributed by Public on 10/24/2025 05:01

Material Agreement, Asset Transaction, Financial Obligation (Form 8-K)

Amended Loan Schedule to Secured Promissory Note dated November 10, 2022

between Acura Pharmaceuticals, Inc. and Abuse Deterrent Pharma, LLC

Date Principal Aggregated Principal
Original Secured Promissory Note 11/10/2022 $ 2,319,279 $ 2,319,279
Additional Loans to be included:
Loans #1 dated 12/22/2022 through Loan #26 dated 12/12/2024 $ 4,625,000 $ 6,944,279
Loan #27 1/13/2025 $ 125,000 $ 7,069,279
Loan #28 1/23/2025 $ 100,000 $ 7,169,279
Loan #29 2/03/2025 $ 125,000 $ 7,294,279
Loan #30 2/14/2025 $ 100,000 $ 7,394,279
Loan #31 2/28/2025 $ 100,000 $ 7,494,279
Loan #32 3/17/2025 $ 100,000 $ 7,594,279
Loan #33 4/04/2025 $ 100,000 $ 7,694,279
Loan #34 4/18/2025 $ 100,000 $ 7,794,279
Loan #35 5/02/2025 $ 100,000 $ 7,894,279
Loan #36 5/22/2025 $ 100,000 $ 7,994,279
Loan #37 6/03/2025 $ 100,000 $ 8,094,279
Loan #38 6/20/2025 $ 100,000 $ 8,194,279
Loan #39 7/03/2025 $ 100,000 $ 8,294,279
Loan #40 7/18/2025 $ 100,000 $ 8,394,279
Loan #41 8/01/2025 $ 100,000 $ 8,494,279
Loan #42 8/15/2025 $ 100,000 $ 8,594,279
Loan #43 9/03/2025 $ 100,000 $ 8,694,279
Loan #44 9/12/2025 $ 100,000 $ 8,794,279
Loan #45 10/06/2025 $ 100,000 $ 8,894,279
Loan #46 10/23/2025 $ 100,000 $ 8,994,279

ACURA PHARMACEUTICALS, INC.

By: /s/ Robert A. Seiser
Robert A. Seiser
Senior Vice President & CFO
Date: October 23, 2025
Acura Pharmaceuticals Inc. published this content on October 24, 2025, and is solely responsible for the information contained herein. Distributed via Edgar on October 24, 2025 at 11:01 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]